High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.
暂无分享,去创建一个
Z. Vered | R. Yogev | Y. Moshkovitz | E. Kaluski | G. Cotter | R. Krakover | I. Shpirer | A. Blatt | A. Golik | A. Sharon | O. Shaham | D. Stav | R. Polak | O. Milovanov | Y. Moshkovitz | M. Metzger | A. Sharon | A. Simovitz | R. Yogev | Z. Faigenberg | Ori Shaham | Roman Polak | Avi Simovitz | Zvi Faigenberg
[1] J. Bronzwaer,et al. Myocardial contractile effects of nitric oxide. , 2002 .
[2] J. Masip,et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial , 2000, The Lancet.
[3] P. Mcdermott,et al. Effect of ED management on ICU use in acute pulmonary edema. , 1999, The American journal of emergency medicine.
[4] T. Welte,et al. The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema , 1999, Intensive Care Medicine.
[5] S. Gayol,et al. Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE) , 1999, Intensive Care Medicine.
[6] S. Keenan,et al. The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. , 1998, Chest.
[7] A. Sakamoto,et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. , 1998, Japanese circulation journal.
[8] Y. Moshkovitz,et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.
[9] M. L. Sica,et al. Intravenous nitrates in the prehospital management of acute pulmonary edema. , 1997, Annals of emergency medicine.
[10] G. Jay,et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. , 1997, Critical care medicine.
[11] B. Lüderitz,et al. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function. , 1997, The American journal of cardiology.
[12] D. Northridge,et al. Frusemide or nitrates for acute heart failure? , 1996, The Lancet.
[13] J. Floras,et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. , 1995, Circulation.
[14] W. Hsueh,et al. Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. , 1994, Circulation.
[15] F. Russel,et al. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance , 1994, Journal of internal medicine.
[16] A. Dimarco,et al. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. , 1994, Chest.
[17] J Ludbrook,et al. Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.
[18] M. Lee,et al. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide , 1986, Biopharmaceutics & drug disposition.
[19] D. Hartmann,et al. Two-site direct immunoassay specific for active renin. , 1992, Clinical chemistry.
[20] M. Lahav,et al. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. , 1992, Chest.
[21] G. Sutton,et al. Heart Failure in a District General Hospital , 1992, Journal of the Royal College of Physicians of London.
[22] F. Russel,et al. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers , 1992, Clinical pharmacology and therapeutics.
[23] N. Kissoon,et al. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients , 1992, Critical care medicine.
[24] A D Bersten,et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. , 1991, The New England journal of medicine.
[25] J. Horowitz,et al. Acute heart failure: determinants of outcome. , 1991, International journal of cardiology.
[26] D. Brater,et al. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. , 1991, Annals of internal medicine.
[27] J. Puschett,et al. Acid-base disturbances in cardiogenic pulmonary edema. , 1991, Nephron.
[28] J. Magovern,et al. Diuresis in hemodynamically compromised patients: continuous furosemide infusion. , 1990, The Annals of thoracic surgery.
[29] A. Tarral,et al. Acute pulmonary oedema: preliminary results of a randomized trial of the intravenous phosphodiesterase inhibitor, enoximone, vs conventional therapy. , 1990, International journal of cardiology.
[30] A. J. Man in 't Veld,et al. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. , 1989, Journal of chromatography.
[31] F. Russel,et al. Solid-phase extraction of furosemide from plasma and urine and subsequent analysis by high-performance liquid chromatography. , 1989, Journal of chromatography.
[32] R. Fish,et al. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. , 1988, Circulation.
[33] C. Harf,et al. Emergency treatment of severe cardiogenic pulmonary edema with intravenous isosorbide-5-mononitrate. , 1988, The American journal of cardiology.
[34] P. Gerlag,et al. High-dose furosemide in the treatment of refractory congestive heart failure. , 1988, Archives of internal medicine.
[35] Amber Denomme,et al. Pulmonary edema. , 1988, Journal of thoracic imaging.
[36] P. Chouraqui,et al. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology. , 1988, European heart journal.
[37] J. Hoffman,et al. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. , 1987, Chest.
[38] S. Gottlieb,et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.
[39] J. Räsänen,et al. Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema. , 1987, Chest.
[40] J. Goldberger,et al. Prognostic factors in acute pulmonary edema. , 1986, Archives of internal medicine.
[41] J. Mackenzie,et al. Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. , 1986, Chest.
[42] M. Winniford,et al. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. , 1986, Circulation.
[43] J. Katz,et al. Inspiratory Work with and without Continuous Positive Airway‐Pressure in Patients with Acute Respiratory Failure , 1985, Anesthesiology.
[44] J. Cohn,et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.
[45] L. Paalzow,et al. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. , 1985, The Journal of pharmacology and experimental therapeutics.
[46] J. Heikkilä,et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. , 1985, The American journal of cardiology.
[47] J. Copeland,et al. Diuresis with continuous infusion of furosemide after cardiac surgery. , 1983, American journal of surgery.
[48] E. Antman,et al. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.
[49] S. Taylor,et al. HAEMODYNAMIC ADVANTAGES OF ISOSORBIDE DINITRATE OVER FRUSEMIDE IN ACUTE HEART-FAILURE FOLLOWING MYOCARDIAL INFARCTION , 1983, The Lancet.
[50] D. Brater,et al. The time course of delivery of furosemide into urine: an independent determinant of overall response. , 1982, Kidney international.
[51] Rybakova Lp. Pathophysiology of furosemide ototoxicity. , 1982 .
[52] D. Brater,et al. Furosemide in patients with heart failure: Shift in dose‐response curves , 1980, Clinical pharmacology and therapeutics.
[53] M. Weil,et al. Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema. , 1979, The American journal of cardiology.
[54] T. Biddle,et al. Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction. , 1979, The American journal of cardiology.
[55] D. Leaman,et al. The Effects of Morphine on Venous Tone in Patients with Acute Pulmonary Edema , 1976, Circulation.
[56] B. Pitt,et al. The Role of Furosemide in the Treatment of Left Ventricular Dysfunction Associated with Acute Myocardial Infarction , 1973, Circulation.
[57] M. Fulop,et al. The metabolic and respiratory acidosis of acute pulmonary edema. , 1972, Annals of internal medicine.
[58] D. Flenley,et al. Blood-gas exchange after frusemide in acute pulmonary oedema. , 1971, Lancet.
[59] J. Murtagh,et al. Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures. , 1969, British heart journal.
[60] A. Rabiner. [ON THE TREATMENT OF ACUTE PULMONARY EDEMA]. , 1964, Klinicheskaia meditsina.
[61] A. L. Simon,et al. Correlations Between the Chest Film and Hemodynamics in Acute Myocardial Infarction , 1973, Medical services journal, Canada.